| Net Cash Provided by (Used in) Operating Activities |
$347,500,000 |
USD |
-45% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$2,807,800,000 |
USD |
29% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$2,536,400,000 |
USD |
-26% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
2,500 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$87,700,000 |
USD |
-4.6% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,940,500,000 |
USD |
3.3% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$4,600,000 |
USD |
-55% |
Q3 2024 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$880,900,000 |
USD |
86% |
Q4 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
$10,100,000 |
USD |
-104% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$59,200,000 |
USD |
-1% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$190,200,000 |
USD |
3.3% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$196,100,000 |
USD |
1.3% |
Q3 2025 |
FY 2025 |
| Interest Expense |
$2,362,000,000 |
USD |
-7.6% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |